Tracked deals
6
6 tracked deals across 2022-2024.
Private Equity Firm
Healthcare
Elyan Partners
Paris, Île-de-France, France
Elyan Partners is a mid-market investor focusing on high value creation across Europe and North America. It invests with a thesis-driven approach, partnering with management teams and like-minded investors, and is part of the Edmond de Rothschild Private Equity partnership. Focus areas include Healthcare Services, the digitalization of B2B services, and the new consumer.
- Focus Areas
- Healthcare Services, Digitalization of B2B Services, The New Consumer
- Website
- elyan.com
Recent pace
0
0 tracked deals announced in the last 12 months.
Deal mix
Buyout
3 buyout · 2 growth capital · 1 addon
Elyan Partners Acquisition Volume by Year
Last 3 years
Supporting Data
Recent Transactions
-
March 26, 2024
- Buyer
- Elyan Partners, H.I.G. WhiteHorse Europe, Caisse d'Epargne et de Prévoyance Hauts de France
- Target
- Stordata
- Seller
- Founders and executives of Stordata
- Industry
- IT Services
- Location
- Île-de-France, France
- Type
- Buyout
Funds advised by Elyan Partners (Edmond de Rothschild Private Equity) have acquired a majority stake in Stordata, a Versailles-based IT services and data management specialist. The acquisition was financed via a bespoke debt package arranged by H.I.G. WhiteHorse Europe with participation from Caisse d'Epargne et de Prévoyance Hauts de France to support Stordata's expansion and a buy-and-build strategy focused on cloud and cybersecurity.
-
- Buyer
- Keensight Capital, ERES IV (advised by Elyan Partners), Sodena
- Target
- Biovian, 3P Biopharmaceuticals
- Industry
- Biotechnology
- Location
- Navarre, Spain
- Type
- Buyout
Biovian and 3P Biopharmaceuticals have combined under their common shareholder Keensight Capital to form 3PBIOVIAN, a pan‑European biologics CDMO offering end‑to‑end development and manufacturing across microbial and mammalian protein expression, viral vectors, cell therapy and plasmid DNA. The combined group will operate sites in Pamplona‑Noáin (Spain) and Turku (Finland), maintain a commercial office in Boston, and employ over 500 professionals with gross sales above €75m; ERES IV (advised by Elyan Partners) and Sodena will remain minority shareholders alongside Keensight.
-
- Buyer
- ERES IV (Edmond de Rothschild Private Equity / Elyan Partners), Unigestion, Riverside Acceleration Capital, Founders of FreightWise
- Target
- FreightWise
- Industry
- Logistics & Distribution
- Location
- Tennessee, United States
- Type
- Growth capital
ERES IV (advised by Elyan Partners) has led a $25 million growth investment in FreightWise, the US-based logistics technology company, alongside FreightWise’s founders, Unigestion and Riverside Acceleration Capital. The capital will be used to scale the company’s customer base and team, expand product capabilities and pursue organic and acquisitive growth across North America.
-
- Buyer
- Oncodesign Services, Nov Santé Actions Non Cotées (Eurazeo), ERES IV SLP / Edmond de Rothschild Private Equity
- Target
- ZoBio
- Industry
- Biotechnology
- Location
- South Holland, Netherlands
- Type
- Addon
Oncodesign Services, majority-held by ERES IV SLP (Edmond de Rothschild Private Equity), has acquired Dutch fragment-based drug discovery specialist ZoBio to strengthen its upstream Drug Discovery capabilities. Concurrently, Nov Santé Actions Non Cotées (managed by Eurazeo) has invested in Oncodesign Services to support external growth and the group's international expansion.
-
July 1, 2022
- Buyer
- Edmond de Rothschild Equity Strategies IV SLP (ERES IV), Elyan Partners
- Target
- Oncodesign Services (Oncodesign / ODS)
- Seller
- Philippe Genne (via holding P.C.G.) and other principal shareholders, certain managers and minority shareholders
- Industry
- Healthcare Services
- Location
- Bourgogne-Franche-Comté, France
- Type
- Buyout
Edmond de Rothschild Equity Strategies IV SLP (ERES IV), advised by Elyan Partners, acquired a majority stake in Oncodesign Services (ODS), taking control of a 61.58% block and announcing a planned simplified tender offer (OPAS) for the remaining shares. The transaction separates Oncodesign's Services and Biotech businesses and positions ODS for accelerated organic growth and potential bolt-on acquisitions under continued management involvement from founder Philippe Genne and CEO Fabrice Viviani.
-
January 24, 2022
- Buyer
- True Wind Capital, Elyan Partners, Palladium Equity Partners
- Target
- Envoy Global
- Industry
- Cloud & SaaS
- Location
- Illinois, United States
- Type
- Growth capital
True Wind Capital and Elyan Partners have made a growth investment in Envoy Global, partnering with existing shareholder Palladium Equity Partners to support the immigration software and services provider's next phase of growth. The new investors will help Envoy scale its technology platform and expand its services internationally, particularly into Europe.
Related Acquisition Pages
Biotechnology Buyers & Acquisitions
2 tracked deals by Elyan Partners.
Cloud & SaaS Buyers & Acquisitions
1 tracked deal by Elyan Partners.
Healthcare Services Buyers & Acquisitions
1 tracked deal by Elyan Partners.
IT Services Buyers & Acquisitions
1 tracked deal by Elyan Partners.
Acquisitions in Illinois
1 tracked deal by Elyan Partners.
Acquisitions in Tennessee
1 tracked deal by Elyan Partners.
Selling a company? Get in front of buyers like Elyan Partners
Turn tracked acquisition activity into an outreach-ready buyer list.